150 related articles for article (PubMed ID: 30350180)
1. The role of
Yi C; Shi X; Zhang X; Luo G; Zhang B; Zhang X
Ann Nucl Med; 2019 Jan; 33(1):61-67. PubMed ID: 30350180
[TBL] [Abstract][Full Text] [Related]
2. One-day protocol for
Chang Y; Donglan Y; Xinchong S; Ganhua L; Bing Z; Yao L; Rutong Z; Qiao H; Xiangsong Z
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(2):68-74. PubMed ID: 32005511
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of
He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X
BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma.
Rapp M; Heinzel A; Galldiks N; Stoffels G; Felsberg J; Ewelt C; Sabel M; Steiger HJ; Reifenberger G; Beez T; Coenen HH; Floeth FW; Langen KJ
J Nucl Med; 2013 Feb; 54(2):229-35. PubMed ID: 23232275
[TBL] [Abstract][Full Text] [Related]
5. 13N-ammonia combined with 18F-FDG could discriminate between necrotic high-grade gliomas and brain abscess.
Shi X; Yi C; Wang X; Zhang B; Chen Z; Tang G; Zhang X
Clin Nucl Med; 2015 Mar; 40(3):195-9. PubMed ID: 25546194
[TBL] [Abstract][Full Text] [Related]
6. 13N-Ammonia PET/CT for detection of recurrent glioma: a prospective comparison with contrast-enhanced MRI.
Khangembam BC; Sharma P; Karunanithi S; Singhal A; Das CJ; Kumar P; Julka PK; Bandopadhyaya GP; Kumar R; Malhotra A; Bal C
Nucl Med Commun; 2013 Nov; 34(11):1046-54. PubMed ID: 24025920
[TBL] [Abstract][Full Text] [Related]
7. The comparison of 13N-ammonia and 18F-FDG in the evaluation of untreated gliomas.
Shi X; Liu Y; Zhang X; Yi C; Wang X; Chen Z; Zhang B
Clin Nucl Med; 2013 Jul; 38(7):522-6. PubMed ID: 23698463
[TBL] [Abstract][Full Text] [Related]
8. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
Li DL; Xu YK; Wang QS; Wu HB; Li HS
Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
[TBL] [Abstract][Full Text] [Related]
9. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
10. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
11. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
Song PJ; Lu QY; Li MY; Li X; Shen F
J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas.
Röhrich M; Huang K; Schrimpf D; Albert NL; Hielscher T; von Deimling A; Schüller U; Dimitrakopoulou-Strauss A; Haberkorn U
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1573-1584. PubMed ID: 29732524
[TBL] [Abstract][Full Text] [Related]
13. Proton magnetic resonance spectroscopy differentiates tumefactive demyelinating lesions from gliomas.
Ikeguchi R; Shimizu Y; Abe K; Shimizu S; Maruyama T; Nitta M; Abe K; Kawamata T; Kitagawa K
Mult Scler Relat Disord; 2018 Nov; 26():77-84. PubMed ID: 30237108
[TBL] [Abstract][Full Text] [Related]
14. Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions.
Kuwert T; Morgenroth C; Woesler B; Matheja P; Palkovic S; Vollet B; Samnick S; Maasjosthusmann U; Lerch H; Gildehaus FJ; Wassmann H; Schober O
Eur J Nucl Med; 1996 Oct; 23(10):1345-53. PubMed ID: 8781139
[TBL] [Abstract][Full Text] [Related]
15. The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PET.
Malkowski B; Harat M; Zyromska A; Wisniewski T; Harat A; Lopatto R; Furtak J
PLoS One; 2015; 10(10):e0140917. PubMed ID: 26468649
[TBL] [Abstract][Full Text] [Related]
16. 18F-fluoro-ethyl-tyrosine positron emission tomography for grading and estimation of prognosis in patients with intracranial gliomas.
Gempt J; Bette S; Ryang YM; Buchmann N; Peschke P; Pyka T; Wester HJ; Förster S; Meyer B; Ringel F
Eur J Radiol; 2015 May; 84(5):955-62. PubMed ID: 25748815
[TBL] [Abstract][Full Text] [Related]
17. PET Imaging of cerebral astrocytoma with 13N-ammonia.
Xiangsong Z; Changhong L; Weian C; Dong Z
J Neurooncol; 2006 Jun; 78(2):145-51. PubMed ID: 16739028
[TBL] [Abstract][Full Text] [Related]
18. Ability of (18)F-DOPA PET/CT and fused (18)F-DOPA PET/MRI to assess striatal involvement in paediatric glioma.
Morana G; Puntoni M; Garrè ML; Massollo M; Lopci E; Naseri M; Severino M; Tortora D; Rossi A; Piccardo A
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1664-72. PubMed ID: 26911489
[TBL] [Abstract][Full Text] [Related]
19. FDOPA PET-CT of Nonenhancing Brain Tumors.
Bund C; Heimburger C; Imperiale A; Lhermitte B; Chenard MP; Lefebvre F; Kremer S; Proust F; Namer IJ
Clin Nucl Med; 2017 Apr; 42(4):250-257. PubMed ID: 28114224
[TBL] [Abstract][Full Text] [Related]
20. The combination of 13N-ammonia and 18F-FDG in predicting primary central nervous system lymphomas in immunocompetent patients.
Shi X; Zhang X; Yi C; Wang X; Chen Z; Zhang B
Clin Nucl Med; 2013 Feb; 38(2):98-102. PubMed ID: 23334122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
